Sol-Gel Technologies (SLGL) Change in Receivables (2019 - 2023)

Sol-Gel Technologies (SLGL) reported Change in Receivables of $2.2 million for Q2 2023, down 78.33% year-over-year from $10.2 million in Q2 2022, and down 62.02% quarter-over-quarter from $5.8 million in Q1 2023.

Sol-Gel Technologies (SLGL) Change in Receivables (2019 - 2023) Analysis & Trends

Sol-Gel Technologies (SLGL) has 5 years of Change in Receivables data on file, last reported at $2.2 million in Q2 2023.

  • Change in Receivables for Q2 2023 came in at $2.2 million, down 78.33% year-over-year; the trailing twelve-month figure through Jun 2023 was $2.2 million (down 78.33% YoY), and the FY2024 annual result was $3.2 million, up 921.59% from the prior year.
  • Change in Receivables eased to $2.2 million in Q2 2023 per SLGL's latest filing, from $5.8 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $13.1 million in Q4 2021 and troughed at $706000.0 in Q1 2021.
  • A 5-year average of $5.3 million and a median of $4.2 million in 2019 frame the typical range for Change in Receivables.
  • The sharpest annual moves came in 2020 and 2022: Change in Receivables tumbled 85.04% in 2020, then soared 1268.27% in 2022.
  • A 5-year view of Change in Receivables shows it stood at $4.8 million in 2019, then slumped by 55.13% to $2.2 million in 2020, then surged by 506.83% to $13.1 million in 2021, then slumped by 39.85% to $7.9 million in 2022, then plunged by 71.94% to $2.2 million in 2023.
  • Business Quant data shows SLGL's Change in Receivables at $2.2 million in Q2 2023, $5.8 million in Q1 2023, and $7.9 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 22,529.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -39.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -4.08 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 2.21 Mn
Jun 30, 2023 2.21 Mn
Mar 31, 2023 5.81 Mn
Mar 31, 2023 5.81 Mn
Dec 31, 2022 7.86 Mn
Dec 31, 2022 7.86 Mn
Sep 30, 2022 10.78 Mn
Sep 30, 2022 10.78 Mn
Jun 30, 2022 10.18 Mn
Jun 30, 2022 10.18 Mn
Mar 31, 2022 9.66 Mn
Mar 31, 2022 9.66 Mn
Dec 31, 2021 13.07 Mn
Dec 31, 2021 13.07 Mn
Sep 30, 2021 1.39 Mn
Sep 30, 2021 1.39 Mn
Jun 30, 2021 956,000.00
Jun 30, 2021 956,000.00
Mar 31, 2021 706,000.00
Mar 31, 2021 706,000.00